Radiation and Anti-Cancer Vaccines: A Winning Combination
/in Dendritic Cells, International Publications /von 2018-01-30 / Vaccines (Basel) 2018 Jan;6(1)Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8 T cell activation in the presence of adjuvant temozolomide
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-01-29 / Oncoimmunology 2018;7(4):e1412901Autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: An analysis of immunological responses.
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-01-26 / J Clin Oncol 36, 2018 (suppl 5S; abstr 96)A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an autologous tumor lysate + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC and embedded phase I/IIa trial with tumor lysate particle only (TLPO) vaccine in stage III and stage IV (resected) melanoma to prevent recurrence.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-01-25 / J Clin Oncol 36, 2018 (suppl 5S; abstr TPS201)The effect of modulated electro-hyperthermia on temperature and blood flow in human cervical carcinoma
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-01-21 / Int J Hyperthermia 2018 11;34(7):953-960Hyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death
/in Colorectal Cancer, Hyperthermia, International Publications /von 2018-01-11 / J. Cell. Biochem. 2018 04;119(4):3763-3774A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2018-01-10 / Oncotarget 2018 Feb;9(11):10110-10117Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2018-01-09 / Cancer Sci. 2018 Feb;109(2):279-288Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-01-03 / Sci Transl Med 2018 01;10(422)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de